Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sofi Sennefelt Nyman
Observed name:
Sennefelt Nyman, Sofi
Institution:
Uppsala University
Observed institution:
Uppsala University
ORCID:
0000-0002-8911-2927
Observed ORCID:
0000-0002-8911-2927
OpenAlex ID:
A5020188653
Inhibiting the endoplasmic reticulum stress response enhances the effect of doxorubicin by altering the lipid metabolism of liver cancer cells
2023
·
Maria Kopsida
, Ada Lerma Clavero
, et al.
·
Molecular Metabolism
·
31
Study protocol for locoregional precision treatment of hepatocellular carcinoma with transarterial chemoembolisation (TACTida), a clinical study: idarubicin dose selection, tissue response and survival
2022
·
Sofi Sennefelt Nyman
, Håkan Ahlström
, et al.
·
BMJ Open
·
8
PDF
Peritumoral portal enhancement during transarterial chemoembolization: a potential prognostic factor for patients with hepatocellular carcinoma
2021
·
Sofi Sennefelt Nyman
, Angeliki Dimopoulou Creusen
, et al.
·
Acta Radiologica
·
3
Inhibition of PERK signaling suppresses tumor progression and blocks GP73-GRP78-dependent stromal activation in hepatocellular carcinoma
2026
·
Jaafar Khaled
, Maria Kopsida
, et al.
·
Neoplasia
·
1
Characterization of hepatocellular carcinoma patient-derived organoids from patients receiving transarterial chemoembolization as a model for preclinical drug response assessment
2026
·
Jaafar Khaled
, Sofi Sennefelt Nyman
, et al.
·
Scientific Reports
PDF
ER-stress Inhibitors Study on HCC
2026
·
Khaled, Jaafar
, Kopsida, Maria
, et al.
·
SciLifeLab Data Repository
Exploring Hepatocellular Carcinoma to Improve Transarterial Chemoembolization
2026
·
Sennefelt Nyman, Sofi
·
DiVA (Digitala Vetenskapliga Arkivet)
Show more works
View as search
Works count:
7
Citation count:
43
H-index:
3
I10-index:
1
Year
Topic
Type